Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Senokot Max Strength tablet 12 Years Plus
0106020M0BBAFAP
|
Senokot (Senna) | Senna | Gastro-Intestinal System | 541 |
|
Senokot 7.5mg tablets 12 Years Plus (Reckitt)
0106020M0BBAKAC
|
Senokot (Senna) | Senna | Gastro-Intestinal System | 389 |
|
Senokot 7.5mg/5ml syrup
0106020M0BBABAE
|
Senokot (Senna) | Senna | Gastro-Intestinal System | 25 |
|
Senokot 7.5mg tablets Adult
0106020M0BBAJAC
|
Senokot (Senna) | Senna | Gastro-Intestinal System | 23 |
|
Senokot 7.5mg tablets 12 Years Plus (Forum)
0106020M0BBAEAC
|
Senokot (Senna) | Senna | Gastro-Intestinal System | 10 |
|
Senokot Max Strength tablets Adult
0106020M0BBAIAP
|
Senokot (Senna) | Senna | Gastro-Intestinal System | 6 |
|
Senokot 15mg/5ml granules
0106020M0BBAAAD
|
Senokot (Senna) | Senna | Gastro-Intestinal System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.